Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
✍ Scribed by Piotr Lewczuk; Johannes Kornhuber; Hugo Vanderstichele; Eugeen Vanmechelen; Hermann Esselmann; Mirko Bibl; Stefanie Wolf; Markus Otto; Udo Reulbach; Heike Kölsch; Frank Jessen; Johannes Schröder; Peter Schönknecht; Harald Hampel; Oliver Peters; Erik Weimer; Robert Perneczky; Holger Jahn; Christian Luckhaus; Ulrich Lamla; Tillmann Supprian; Juan Manuel Maler; Jens Wiltfang
- Book ID
- 116781069
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 497 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0197-4580
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Alaproclate, a specific inhibitor of neuronal serotonin re-uptake, was given to 12 patients with dementia of Alzheimer type. The drug was rapidly absorbed and an elimination half-life of 7.1 +/- 0.9 h (+/- SD, n = 8) was calculated. Plasma protein binding for alaproclate was 82 +/- 1%. Two weeks of